BioSpace News Archive

Over the course of FY2020, Takeda remained resilient as we operated in new ways through the COVID-19 pandemic.

Galderma has expanded its consumer care portfolio in Switzerland, where the global dermatology company originated and is headquartered.

argenx SE, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, announced that the proposed resolutions presented at its Annual General Meeting of Shareholders, held today at 10:00 a.m. CEST, were duly passed.

CareCentrix, the leader in health-at-home solutions, announced the addition of Dr. Jennifer Schneider, MD, MS, as a strategic advisor.

Berkeley Lights, Inc., a leader in Digital Cell Biology, reported financial results for the quarter ended March 31, 2021.

Harbour BioMed announced the dosing of the first patient in its part 2 of phase I clinical study of its next-generation anti-CTLA-4 antibody, where Australian patients with metastatic or advanced melanoma, hepatocellular carcinoma and renal cell carcinoma and other type of tumors will be enrolled.

Scale of Excelera Network and proprietary data platform leveraged to simplify real-world analysis of patient compliance with pre-treatment screenings prior to biologic therapy use

Funding to Advance Parallel Lead Programs in ROS1-positive and ALK-positive NSCLC to Phase 1/2 Clinical Trials and Expand Discovery Research Pipeline

Caption Health, a leading medical artificial intelligence company driving better health outcomes by increasing access to ultrasound, shared that its Caption AI ultrasound technology is being utilized by the United States Naval Medical Research Center for the second phase of its COVID-19 Health Action Response for Marines study, now underway.

Passage Bio collaborator University of Pennsylvania’s Gene Therapy Program to present poster regarding development of a novel mouse model for evaluating efficacy of adeno-associated virus gene therapy for metachromatic leukodystrophy (MLD)